CitraVet™ offers a better way to manage Urolithiasis
CitraVet, the newest addition to the PRN Pharmacal product lineup, offers a better way to manage Urolithiasis (recurring urinary stones) and overall urinary health in at-risk patients. Urolithiasis is a common problem in dogs and cats, especially male dogs approaching middle age. The recurrence of uroliths in cats is up to 70% and in dogs is 35%. As surgery is often the only treatment option, urinary health management should be the first line of defense.
CitraVet, liver-flavored chewable tablets contain 675 mg of potassium citrate and is formulated for both dogs and cats. CitraVet can be used alone or with a maintenance program to support overall urinary health.
Managing at-risk patient health is becoming more important in this economy. Pet owners struggle to pay high costs of treatments and surgery, CitraVet complements our CranMateŽ product launched earlier this year." stated PRN Pharmacal Vice-President of Sales, Gary Cushing. "Our products offer veterinarians and pet owners cost-effective solutions for total health management.
CitraVet is manufactured by Pegasus Laboratories, Inc. under the PRN Pharmacal brand and is available nation-wide through veterinary distributors. Pegasus has over 30 years of service to the veterinary pharmaceutical industry with a production facility in Pensacola, Florida. For more information on CranVet, visit prnpharmacal.com/cranvet or call 1-800-874-9764.